Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Fukiko Kitani-Morii"'
Autor:
Takuma Ohmichi, Takashi Kasai, Makiko Shinomoto, Fukiko Kitani-Morii, Yuzo Fujino, Kanako Menjo, Toshiki Mizuno
Publikováno v:
PLoS ONE, Vol 18, Iss 2 (2023)
There is ample epidemiological and animal-model evidence suggesting that intestinal inflammation is associated with the development of Parkinson’s disease (PD). Leucine-rich α2 glycoprotein (LRG) is a serum inflammatory biomarker used to monitor t
Externí odkaz:
https://doaj.org/article/fbbe7133c35d4a29bfad87658d5c2b7a
Autor:
Takashi Kasai, Yuta Kojima, Takuma Ohmichi, Harutsugu Tatebe, Yukiko Tsuji, Yu‐ichi Noto, Fukiko Kitani‐Morii, Makiko Shinomoto, David Allsop, Toshiki Mizuno, Takahiko Tokuda
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 6, Iss 12, Pp 2489-2502 (2019)
Abstract Objective To determine the diagnostic and prognostic significance of neurofilament light chain (NfL), TAR DNA‐binding protein 43 (TDP‐43), and total tau (t‐tau) in cerebrospinal fluid (CSF) and plasma of patients with amyotrophic later
Externí odkaz:
https://doaj.org/article/86f29760cde3462d884f3cfd82198694
Autor:
Makiko Shinomoto, Takashi Kasai, Harutsugu Tatebe, Fukiko Kitani-Morii, Takuma Ohmichi, Yuzo Fujino, David Allsop, Toshiki Mizuno, Takahiko Tokuda
Publikováno v:
Translational Neurodegeneration, Vol 10, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/68fb567fa5ee4e27844fbe696160536b
Autor:
Fukiko Kitani-Morii, Takashi Kasai, Go Horiguchi, Satoshi Teramukai, Takuma Ohmichi, Makiko Shinomoto, Yuzo Fujino, Toshiki Mizuno
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245864 (2021)
The worsening of neuropsychiatric symptoms such as depression, anxiety, and insomnia in patients with Parkinson's disease (PD) has been a concern during the COVID-19 pandemic, because most people worked in self-isolation for fear of infection. We aim
Externí odkaz:
https://doaj.org/article/30ecf8acb3be4b90906613484625f99c
Autor:
Yuta Kojima, Takashi Kasai, Yu-Ichi Noto, Takuma Ohmichi, Harutsugu Tatebe, Takamasa Kitaoji, Yukiko Tsuji, Fukiko Kitani-Morii, Makiko Shinomoto, David Allsop, Satoshi Teramukai, Toshiki Mizuno, Takahiko Tokuda
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0260323 (2021)
ObjectivesWe previously reported the diagnostic and prognostic performance of neurofilament light chain (NfL), TAR DNA-binding protein 43 (TDP-43), and total tau (t-tau) in cerebrospinal fluid (CSF) and plasma as amyotrophic lateral sclerosis (ALS) b
Externí odkaz:
https://doaj.org/article/f8604d5267cb4fb499b7d4aabba5829d
Autor:
Takuma Ohmichi, Takashi Kasai, Makiko Shinomoto, Jun Matsuura, Takashi Koizumi, Fukiko Kitani-Morii, Harutsugu Tatebe, Hidenao Sasaki, Toshiki Mizuno, Takahiko Tokuda
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Caffeine is considered to be a neuroprotective agent against Parkinson's disease (PD) and is expected to offer a blood-based biomarker for the disease. We herein investigated the ability of this biomarker to discriminate between PD and neurodegenerat
Externí odkaz:
https://doaj.org/article/9fd87767385e4b8eb25577f7a1f5ef65
Autor:
Fukiko Kitani-Morii, Yu-ichi Noto, Yukiko Tsuji, Kensuke Shiga, Ikuko Mizuta, Masanori Nakagawa, Toshiki Mizuno
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Introduction: We aimed to clarify when adult patients with Charcot-Marie-Tooth disease type 1A (CMT1A), especially those diagnosed at middle or advanced ages, first showed symptoms and whether the rate of disease progression is accelerated by aging.M
Externí odkaz:
https://doaj.org/article/f4aa54a1d67b413ba1eebf1fed977162
Autor:
Fukiko Kitani-Morii, Yu-ichi Noto
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 19, p 7419 (2020)
Charcot-Marie-Tooth disease (CMT) is one of the most common inherited peripheral neuropathies. CMT patients typically show slowly progressive muscle weakness and sensory loss in a distal dominant pattern in childhood. The diagnosis of CMT is based on
Externí odkaz:
https://doaj.org/article/cfcbd432cfed4eb698d49112ee1a7156
Autor:
Yuka Okabe, Yukiko Tsuji, Yu-ichi Noto, Takamasa Kitaoji, Yuta Kojima, Fukiko Kitani-Morii, Toshiki Mizuno, Masanori Nakagawa
Publikováno v:
Rinsho Shinkeigaku.
Autor:
Yuzo Fujino, Toshiki Mizuno, Takashi Kasai, Fukiko Kitani-Morii, Takuma Ohmichi, Kanako Menjo, Makiko Shinomoto
Publikováno v:
Parkinsonism & Related Disorders. 91:128-134
Background Impaired bioenergetics are partially involved in the pathogenesis of Parkinson's disease (PD). Phosphoglycerate kinase (PGK), an essential enzyme for glycolysis, has recently attracted attention due to its pathogenic role in PD and as a ta